772 related articles for article (PubMed ID: 28731198)
1. GSK-3β inhibition suppresses instability-induced osteolysis by a dual action on osteoblast and osteoclast differentiation.
Amirhosseini M; Madsen RV; Escott KJ; Bostrom MP; Ross FP; Fahlgren A
J Cell Physiol; 2018 Mar; 233(3):2398-2408. PubMed ID: 28731198
[TBL] [Abstract][Full Text] [Related]
2. Fluoride promotes osteoblastic differentiation through canonical Wnt/β-catenin signaling pathway.
Pan L; Shi X; Liu S; Guo X; Zhao M; Cai R; Sun G
Toxicol Lett; 2014 Feb; 225(1):34-42. PubMed ID: 24300170
[TBL] [Abstract][Full Text] [Related]
3. Titanium particle-induced osteogenic inhibition and bone destruction are mediated by the GSK-3β/β-catenin signal pathway.
Gu Y; Wang Z; Shi J; Wang L; Hou Z; Guo X; Tao Y; Wu X; Zhou W; Liu Y; Zhang W; Xu Y; Yang H; Xue F; Geng D
Cell Death Dis; 2017 Jun; 8(6):e2878. PubMed ID: 28617442
[TBL] [Abstract][Full Text] [Related]
4. Guhong Injection promotes fracture healing by activating Wnt/beta-catenin signaling pathway in vivo and in vitro.
Sun Z; Jin H; Zhou H; Yu L; Wan H; He Y
Biomed Pharmacother; 2019 Dec; 120():109436. PubMed ID: 31561068
[TBL] [Abstract][Full Text] [Related]
5. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
6. Melatonin attenuates titanium particle-induced osteolysis via activation of Wnt/β-catenin signaling pathway.
Ping Z; Hu X; Wang L; Shi J; Tao Y; Wu X; Hou Z; Guo X; Zhang W; Yang H; Xu Y; Wang Z; Geng D
Acta Biomater; 2017 Mar; 51():513-525. PubMed ID: 28088671
[TBL] [Abstract][Full Text] [Related]
7. Naringin increases osteoprotegerin expression in fibroblasts from periprosthetic membrane by the Wnt/β-catenin signaling pathway.
Yang C; Liu W; Zhang X; Zeng B; Qian Y
J Orthop Surg Res; 2020 Dec; 15(1):600. PubMed ID: 33302980
[TBL] [Abstract][Full Text] [Related]
8. MiR-124 regulates osteoblast differentiation through GSK-3β in ankylosing spondylitis.
Tang SL; Huang QH; Wu LG; Liu C; Cai AL
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6616-6624. PubMed ID: 30402833
[TBL] [Abstract][Full Text] [Related]
9. Pharmaceutical inhibition of glycogen synthetase kinase 3 beta suppresses wear debris-induced osteolysis.
Geng D; Wu J; Shao H; Zhu S; Wang Y; Zhang W; Ping Z; Hu X; Zhu X; Xu Y; Yang H
Biomaterials; 2015 Nov; 69():12-21. PubMed ID: 26275858
[TBL] [Abstract][Full Text] [Related]
10. Adenosine A
Mediero A; Wilder T; Shah L; Cronstein BN
FASEB J; 2018 Jul; 32(7):3487-3501. PubMed ID: 29394106
[TBL] [Abstract][Full Text] [Related]
11. Orally bioavailable GSK-3alpha/beta dual inhibitor increases markers of cellular differentiation in vitro and bone mass in vivo.
Kulkarni NH; Onyia JE; Zeng Q; Tian X; Liu M; Halladay DL; Frolik CA; Engler T; Wei T; Kriauciunas A; Martin TJ; Sato M; Bryant HU; Ma YL
J Bone Miner Res; 2006 Jun; 21(6):910-20. PubMed ID: 16753022
[TBL] [Abstract][Full Text] [Related]
12. Cepharanthine ameliorates titanium particle-induced osteolysis by inhibiting osteoclastogenesis and modulating OPG/RANKL ratio in a murine model.
Liao L; Lin Y; Liu Q; Zhang Z; Hong Y; Ni J; Yu S; Zhong Y
Biochem Biophys Res Commun; 2019 Sep; 517(3):407-412. PubMed ID: 31376931
[TBL] [Abstract][Full Text] [Related]
13. Microtubule actin crosslinking factor 1 promotes osteoblast differentiation by promoting β-catenin/TCF1/Runx2 signaling axis.
Hu L; Su P; Yin C; Zhang Y; Li R; Yan K; Chen Z; Li D; Zhang G; Wang L; Miao Z; Qian A; Xian CJ
J Cell Physiol; 2018 Feb; 233(2):1574-1584. PubMed ID: 28621459
[TBL] [Abstract][Full Text] [Related]
14. Glycogen synthase kinase-3α/β inhibition promotes in vivo amplification of endogenous mesenchymal progenitors with osteogenic and adipogenic potential and their differentiation to the osteogenic lineage.
Gambardella A; Nagaraju CK; O'Shea PJ; Mohanty ST; Kottam L; Pilling J; Sullivan M; Djerbi M; Koopmann W; Croucher PI; Bellantuono I
J Bone Miner Res; 2011 Apr; 26(4):811-21. PubMed ID: 20939016
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of GSK-3β Enhances Osteoblast Differentiation of Human Mesenchymal Stem Cells through Wnt Signalling Overexpressing Runx2.
AlMuraikhi N; Binhamdan S; Alaskar H; Alotaibi A; Tareen S; Muthurangan M; Alfayez M
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108323
[TBL] [Abstract][Full Text] [Related]
16. Effects of WNT1 c.110 T>C and c.505G>T mutations on osteoblast differentiation via the WNT1/β-catenin signaling pathway.
Zhang B; Li R; Wang W; Zhou X; Luo B; Zhu Z; Zhang X; Ding A
J Orthop Surg Res; 2021 Jun; 16(1):359. PubMed ID: 34078411
[TBL] [Abstract][Full Text] [Related]
17. l-Quebrachitol Promotes the Proliferation, Differentiation, and Mineralization of MC3T3-E1 Cells: Involvement of the BMP-2/Runx2/MAPK/Wnt/β-Catenin Signaling Pathway.
Yodthong T; Kedjarune-Leggat U; Smythe C; Wititsuwannakul R; Pitakpornpreecha T
Molecules; 2018 Nov; 23(12):. PubMed ID: 30486330
[TBL] [Abstract][Full Text] [Related]
18. Hyperbaric oxygen promotes osteogenic differentiation of bone marrow stromal cells by regulating Wnt3a/β-catenin signaling--an in vitro and in vivo study.
Lin SS; Ueng SW; Niu CC; Yuan LJ; Yang CY; Chen WJ; Lee MS; Chen JK
Stem Cell Res; 2014 Jan; 12(1):260-74. PubMed ID: 24291646
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss.
Wang FS; Ko JY; Weng LH; Yeh DW; Ke HJ; Wu SL
Life Sci; 2009 Nov; 85(19-20):685-92. PubMed ID: 19782693
[TBL] [Abstract][Full Text] [Related]
20. Attenuated Wnt/β-catenin signalling mediates methotrexate chemotherapy-induced bone loss and marrow adiposity in rats.
Georgiou KR; King TJ; Scherer MA; Zhou H; Foster BK; Xian CJ
Bone; 2012 Jun; 50(6):1223-33. PubMed ID: 22484100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
